New alzheimer’s drug raises hopes – along with questions
A new era of treatment for Alzheimer’s disease has begun with the recent approval of several groundbreaking drugs, notably Leqembi, Aduhelm, and Donanemab. This significant development has sparked both optimism and skepticism within the medical community and beyond. These innovative pharmaceuticals hold the promise of offering much-needed relief to patients grappling with the devastating effects […]
Continue Reading